EcoDrugPlus

Ensembl ID : ENSMLUG00000029078
Gene Symbol: -
Cross references: -
438 Possible Orthologues:

Ensembl ID : ENSMLUG00000029266
Gene Symbol: -
Cross references: -
232 Possible Orthologues:

Ensembl ID : ENSMLUG00000029269
Gene Symbol: -
Cross references: -
162 Possible Orthologues:

Ensembl ID : ENSMLUG00000029340
Gene Symbol: -
Cross references: -
170 Possible Orthologues:

Ensembl ID : ENSMLUG00000029392
Gene Symbol: -
Cross references: -
251 Possible Orthologues:

Ensembl ID : ENSMLUG00000029660
Gene Symbol: -
Cross references: -
256 Possible Orthologues:

Ensembl ID : ENSMLUG00000001256
Gene Symbol: -
Cross references: -
204 Possible Orthologues:

Ensembl ID : ENSMLUG00000030647
Gene Symbol: -
Cross references: -
209 Possible Orthologues:

Ensembl ID : ENSMLUG00000030503
Gene Symbol: -
Cross references: -
138 Possible Orthologues:

Ensembl ID : ENSMLUG00000030430
Gene Symbol: -
Cross references: -
199 Possible Orthologues:

Ensembl ID : ENSMLUG00000030570
Gene Symbol: -
Cross references: -
107 Possible Orthologues:

Ensembl ID : ENSMLUG00000029799
Gene Symbol: -
Cross references: -
193 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).